Please Wait
Applying Filters...
menu
    • menu
    Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

    Data Compilation
    #PharmaFlow

    Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

    Stock Recap
    #PipelineProspector

    Menu

    CDX

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 70Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    29/11/2025 Centrient Pharmaceuticals
    Netherlands
    		 Daewoong Bio Co., Ltd. 20050831-19-A-15-05(3) Cefadroxil hydrate 2019-04-04 Centrient Pharmaceuticals Spain S.A. Spain C/Ripolles, n2 Poligono Industrial URVASA Santa Perpetua de Mogoda 08130 BARCELONA SPAIN (POBox 425, 2600 AK Delft, The Netherlands)
    29/11/2025 Centrient Pharmaceuticals
    Netherlands
    		 Daewoong Pharmaceutical Co., Ltd. 20050831-19-A-15-05(2) Cefadroxil hydrate 2015-05-12 Centrient Pharmaceuticals Spain S.A. Spain C/Ripolles, n2 Poligono Industrial URVASA Santa Perpetua de Mogoda 08130 BARCELONA SPAIN (POBox 425, 2600 AK Delft, The Netherlands)